跳至主要内容
临床试验/NCT01710943
NCT01710943Unknown1 期

Web-based CBT for Substance Misusing and PTSD Symptomatic OEF/OIF Veterans

National Development and Research Institutes, Inc.4 个研究点 分布在 1 个国家目标入组 216 人开始时间: 2010年9月1日最近更新:
适应症

试验速览

阶段
1 期
发起方
入组人数
216
试验地点
4
主要终点
PTSD Symptomatology

研究概览

简要总结

The proposed study involves developing and evaluating an interactive, web-based CBT intervention for OEF/OIF Veterans with hazardous or problematic substance use and PTSD symptoms (PTSD or subsyndromal PTSD). The intervention will address the special culture and experiences of the investigators targeted population (OEF/OIF Veterans). The web-based CBT intervention includes 24 modules, to be used across 24 sessions targeting OEF/OIF Veterans with hazardous or problematic substance use and PTSD symptoms. The investigators ask participants to complete 2 sessions per week (one module per session) for 12 weeks. The first 18 modules to be completed across 18 sessions (9 weeks) are considered core modules relevant to all Veterans in the target population. These modules are designed to reduce posttraumatic stress symptoms as well as reduce and prevent the escalation of problematic substance use. The remaining 6 module topics are considered "optional" and are used based on the interest and clinical need of various sub-groups of VA patients. The study includes initial input as well as feedback on a beta version from experts who have worked with OEF/OIF veterans with PTSD and substance abuse problems as well as input/feedback from the target population (the Veterans themselves). In addition to presenting content grounded in evidence-based CBT interventions, the program also employs state of the art technologies to deliver module content grounded in evidence-based learning principles, including Computer-Assisted Instruction, Computer Simulation and other interactive exercises.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Phase 1: Focus Groups
  • Inclusion Criteria:
  • At least 18 years of age
  • An OEF or OIF veteran (verified via CPRS)
  • Screen positive on the Audit-C (>=3 for women or >= 4 for men) OR screen positive on the PC-PTSD (>=3).
  • Currently receiving primary medical care at a VA Medical Center (verified via CPRS)

排除标准

  • Insufficient ability to understand or provide informed consent
  • Lack sufficient ability to use English to participate in the consent process,
  • Current plan or intent to harm themselves as measured with the suicide assessment in Appendix D after the consent process.
  • Phase 2: Feedback Sessions
  • Inclusion Criteria
  • At least 18 years of age
  • An OEF or OIF veteran (verified via CPRS)
  • Hazardous or harmful substance use as measured by one of the following:
  • AUDIT-C score of >=3 (for women) or >= 4 (for men) OR
  • DAST score of >=2 OR
  • Have exited a controlled environment (e.g., detoxification unit, hospital, or correctional facility) within 30 days of screening AND within 30 days prior to entering the controlled environment report:
  • i. heavy drinking (>3 drinks for women or > 4 drinks for men on one or more days), or ii.use of any illegal drugs, iii.or misuse of prescription drugs (use in excess of the directions or any non-medical use)
  • Screen positive on the PC-PTSD (>=2).
  • Currently receiving primary medical care at a VA Medical Center (verified via CPRS)
  • Exclusion Criteria:
  • Insufficient ability to understand or provide informed consent
  • Lack sufficient ability to use English to participate in the consent process, the computerized intervention or the assessments.
  • Current plan or intent to harm themselves as measured with the suicide assessment in Appendix D administered after the consent process.
  • Phase 3: Randomized Clinical Trial
  • Inclusion Criteria:
  • At least 18 years of age
  • An OEF or OIF veteran (verified via CPRS)
  • Hazardous or harmful substance use as measured by one of the following:
  • AUDIT score of >=7 (for women) or >= 8 (for men) OR
  • DAST score of >=2 OR
  • Have exited a controlled environment (e.g., detoxification unit, hospital, or correctional facility) within 30 days of screening AND within 30 days prior to entering the controlled environment report:
  • i. heavy drinking (>3 drinks for women or > 4 drinks for men on1 or more days) or ii. use of any illegal drugs iii. misuse of prescription drugs (use in excess of the directions or any non-medical use)
  • Determined to have diagnostic-level or PTSD (1 A symptom, 1 B symptom, 3 C symptoms AND 2 D symptoms) or subthreshold PTSD (1 A symptom, 1 B symptom, 3 C symptoms OR 2 D symptoms) on the Clinician Administered PTSD Scale (CAPS).
  • Currently receiving primary medical care at a VA Medical Center (verified via CPRS)
  • Exclusion Criteria:
  • Plans to move out of area within the next three months
  • Currently enrolled in a substance abuse treatment program or receiving treatment for PTSD from a mental health professional (verified via CPRS).
  • Insufficient ability to understand or provide informed consent
  • Lack sufficient ability to use English to participate in the consent process, the computerized intervention or the assessments.
  • In need of alcohol detoxification as determined by a score of > 15 on the Clinical Institute Withdrawal Assessment for Alcohol (CIWA-Ar).
  • Current plan or intent to harm themselves as measured with the suicide assessment in Appendix D administered after the consent process.
  • Medical chart diagnosis of a current psychotic disorder, including schizophrenia or bi-polar disorder
  • Cognitive impairment specified by a medical chart diagnosis. Diagnoses include dementia and moderate to severe traumatic brain injury (TBI). Patients with mild TBI will not be excluded. The Second Level TBI Assessment present in patient medical records can be used to verify the severity of TBI.

结局指标

主要结局

PTSD Symptomatology

时间窗: 3 months post-intervention

Comparing baseline score of the PCL-M to score 3 months post-intervention

Alcohol and Drug Use

时间窗: 3 month post-intervention

Comparing baseline TLFB score to score 3 month post-intervention

Quality of Life

时间窗: 3 month post-intervention

Comparing baseline EuroQOl and WHOQOL-Bref scores to scores at 3 months post-intervention

Cost-Effectiveness

时间窗: 12 weeks

Cost-effectiveness of web-based intervention compared to standard care, as measured by the Brief DATCAP, EuroQol EQ5D, and Non-Study Medical and Other Services (NSMS) scales

次要结局

  • Resiliency and Positive Affect(3 months post-intervention)
  • Insomnia(3 months post-intervention)
  • Psychological Distress(3 months post-intervention)
  • Pain Severity and Pain Interference(3 months post-intervention)
  • Treatment Satisfaction(12 weeks)

研究者

发起方
National Development and Research Institutes, Inc.
申办方类型
Other
责任方
Principal Investigator
主要研究者

Andrew Rosenblum

Director, Institute for Treatment and Services Research

National Development and Research Institutes, Inc.

研究点 (4)

Loading locations...

相似试验